These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 386557)

  • 21. An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A.
    Bendtzen K; Andersen V; Bendixen G
    Acta Allergol; 1975 Jul; 30(2-3):133-49. PubMed ID: 1173991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
    Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
    Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
    [No Abstract]   [Full Text] [Related]  

  • 23. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
    Rocklin RE; Blidy A; Butler J; Minowada J
    J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of lymphokine production by interferon.
    Dinh PN; Béládi I; Rosztóczy I; Tóth M
    J Interferon Res; 1980; 1(1):23-30. PubMed ID: 6180042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of serotonin on lymphokine secretion in vitro.
    Paegelow I; Werner H; Hagen M; Wartner U; Lange P
    Int J Immunopharmacol; 1985; 7(6):889-96. PubMed ID: 3908346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokines and thrombosis. II. Procoagulant activity produced by human lymphocytes stimulated with concanavalin A (con-A).
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):107-15. PubMed ID: 947136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity to platelets in SLE patients with thrombocytopenia: two different types of lymphocyte stimulation.
    Morimoto C; Abe T; Homma M
    Clin Immunol Immunopathol; 1980 Jan; 15(1):1-10. PubMed ID: 6987015
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine.
    Weisbart RH; Golde DW; Spolter L; Eggena P; Rinderknecht H
    Clin Immunol Immunopathol; 1979 Dec; 14(4):441-8. PubMed ID: 389500
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphokines: mediators of delayed hypersensitivity.
    Rocklin RE
    Prog Clin Biol Res; 1981; 58():7-12. PubMed ID: 7022482
    [No Abstract]   [Full Text] [Related]  

  • 32. Species-restriction of rat lymphoid cell migration inhibitory factor.
    Whitacre CC; Miller KC; Paterson PY
    Int Arch Allergy Appl Immunol; 1984; 73(2):108-13. PubMed ID: 6363304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphokines secreted from sodium periodate-treated lymphocytes.
    Bressler JP; Thurman GB; Krzych U; Goldstein AL; Trivers G; Strausser HR
    Cell Immunol; 1980 Sep; 54(2):274-83. PubMed ID: 6251977
    [No Abstract]   [Full Text] [Related]  

  • 34. Mediators of immunity: lymphokines and monokines.
    Rocklin RE; Bendtzen K; Greineder D
    Adv Immunol; 1980; 29():55-136. PubMed ID: 6158261
    [No Abstract]   [Full Text] [Related]  

  • 35. [Examination of lymphokines in patients with hemodialysis (author's transl)].
    Löcsey L; Kálmán K; Hauck M; Kakuk G
    Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence of immunomodulators on lymphokine secretion of radiation-damaged lymphocytes].
    Kowalczyk-Bronisz SH; Paegelow I
    Allerg Immunol (Leipz); 1986; 32(1):57-64. PubMed ID: 2424296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of suppressor activity mediated by concanavalin-A stimulated cells towards aspecific LIF production.
    Beatrice F; Poggio E; Morra B; Cavallo GP; Di Fortunato V; Bussi M; Vercellino M; Sartoris A; Cortesina G
    G Batteriol Virol Immunol; 1982; 75(1-6):16-24. PubMed ID: 6227515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of histamine on leukocyte migration tests in vertebrates. II. Study of the lack of species specificity of leukocyte inhibiting factor--production inhibitor (LIF-PI).
    Rigal D; Monier JC; Mohanna K
    Thymus; 1983; 5(1):53-7. PubMed ID: 6342215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.